Diabetic amyotrophy: a brief review.

Area of Science:

• Neurology
• Endocrinology
• Vascular Medicine

Background:

• Diabetic amyotrophy, first described in 1890, affects elderly patients with type 2 diabetes.
• The exact cause remains debated, with proposed ischaemic and metabolic hypotheses.
• Recent evidence supports a vasculitic etiology leading to nerve ischemia, axonal degeneration, and demyelination.

Purpose of the Study:

• To summarize the clinical features, etiology, and management of diabetic amyotrophy.
• To highlight the current understanding of the vasculitic basis of the condition.
• To discuss treatment options and prognosis.

Main Methods:

• Review of historical and current literature on diabetic amyotrophy.
• Analysis of clinical presentations, including weakness, wasting, pain, and sensory disturbances.
• Evaluation of proposed etiological mechanisms and treatment strategies.

Main Results:

• Diabetic amyotrophy typically presents with asymmetrical weakness and wasting, primarily in the quadriceps, accompanied by severe thigh pain.
• Physical examination reveals muscle weakness, absent tendon jerks (especially patellar), and sometimes extensor plantar responses.
• While prognosis is variable, most patients show functional improvement with optimized diabetes control, physiotherapy, and analgesia, though residual deficits may persist.

Conclusions:

• The prevailing hypothesis for diabetic amyotrophy points to a vasculitic etiology causing nerve damage.
• Conservative management focusing on glycemic control, physiotherapy, and pain relief is standard.
• Intravenous immunoglobulins show promise for significant improvement in severe cases.